The morbidity of subthreshold pediatric bipolar disorder: A systematic literature review and meta-analysis.


Journal

Bipolar disorders
ISSN: 1399-5618
Titre abrégé: Bipolar Disord
Pays: Denmark
ID NLM: 100883596

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 28 11 2018
medline: 26 7 2019
entrez: 28 11 2018
Statut: ppublish

Résumé

The objective of this study was to evaluate the morbidity of subthreshold pediatric bipolar (BP) disorder. We performed a systematic literature search in November 2017 and included studies examining the morbidity of pediatric subthreshold BP. Extracted outcomes included functional impairment, severity of mood symptoms, psychiatric comorbidities, suicidal ideation and behaviors, and mental health treatment. We used meta-analysis to compute the pooled standardized mean difference (SMD) for continuous measures and the pooled risk ratio (RR) for binary measures between two paired groups: subthreshold pediatric BP vs controls and subthreshold pediatric BP vs pediatric BP-I. Eleven papers, consisting of seven datasets, were included. We compared subthreshold pediatric BP (N = 244) to non-BP controls (N = 1125) and subthreshold pediatric BP (N = 643) to pediatric BP-I (N = 942). Subthreshold pediatric BP was associated with greater functional impairment (SMD = 0.61, CI 0.25-0.97), greater severity of mood symptomatology (mania: SMD = 1.88, CI 1.38-2.38; depression: SMD = 0.66, CI 0.52-0.80), higher rates of disruptive behavior (RR = 1.75, CI 1.17-2.62), mood (RR = 1.78, CI 1.29-2.79) and substance use (RR = 2.27, CI 1.23-4.21) disorders, and higher rates of suicidal ideation and attempts (RR = 7.66, CI 1.71-34.33) compared to controls. Pediatric BP-I was associated with greater functional impairment, greater severity of manic symptoms, higher rates of suicidal ideation and attempts, and higher rates of mental health treatment compared to subthreshold pediatric BP. There were no differences between full and subthreshold cases in the severity of depressive symptoms or rates of comorbid disorders. Subthreshold pediatric BP disorder is an identifiable morbid condition associated with significant functional impairment including psychiatric comorbidities and high rates of suicidality.

Identifiants

pubmed: 30480855
doi: 10.1111/bdi.12734
pmc: PMC6393204
mid: NIHMS998751
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Systematic Review

Langues

eng

Pagination

16-27

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH109536
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101519
Pays : United States

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

J Affect Disord. 2013 May;147(1-3):295-303
pubmed: 23219057
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):147-53
pubmed: 26844707
J Clin Psychiatry. 2012 Oct;73(10):1342-50
pubmed: 23140653
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):825-831.e3
pubmed: 28942804
Arch Gen Psychiatry. 2009 Dec;66(12):1341-52
pubmed: 19996039
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):386-399
pubmed: 19252450
J Affect Disord. 2014 Jan;152-154:347-51
pubmed: 24144583
Br J Psychiatry. 2010 Feb;196(2):87-8
pubmed: 20118448
World J Psychiatry. 2015 Mar 22;5(1):126-37
pubmed: 25815262
Arch Gen Psychiatry. 2006 Oct;63(10):1139-48
pubmed: 17015816
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Child Psychol Psychiatry. 2010 Jan;51(1):31-8
pubmed: 19686330
Br J Psychiatry. 2010 Nov;197(5):411-2
pubmed: 21037219
Bipolar Disord. 2017 May;19(3):168-175
pubmed: 28544732
Am J Psychiatry. 2009 Jul;166(7):795-804
pubmed: 19448190
Bipolar Disord. 2013 May;15(3):240-52
pubmed: 23521542
Biol Psychiatry. 2007 Jul 15;62(2):107-14
pubmed: 17306773
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):107-13
pubmed: 26771536
J Affect Disord. 2013 Feb 20;145(2):190-9
pubmed: 22884232
Bipolar Disord. 2012 Aug;14(5):488-96
pubmed: 22713098
Bipolar Disord. 2005 Dec;7(6):623-34
pubmed: 16403188
Bipolar Disord. 2017 Nov;19(7):524-543
pubmed: 28944987
Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):461-75, vii
pubmed: 12222078
Soc Psychiatry Psychiatr Epidemiol. 2015 Mar;50(3):397-406
pubmed: 25358512
JAMA Psychiatry. 2015 Jan;72(1):75-83
pubmed: 25426673
Arch Gen Psychiatry. 2012 Sep;69(9):943-51
pubmed: 22566563
J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):1001-16.e3
pubmed: 21961775
Psychol Med. 2004 May;34(4):613-22
pubmed: 15099416

Auteurs

Carrie A H Vaudreuil (CAH)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Stephen V Faraone (SV)

Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York.

Maura Di Salvo (M)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.

Janet R Wozniak (JR)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Rebecca A Wolenski (RA)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.

Nicholas W Carrellas (NW)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.

Joseph Biederman (J)

Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH